在医疗技术评估中使用R进行决策分析建模的障碍和促进因素:焦点小组结果
Yanara Marks1, Jeffrey S Hoch2, Anna Heath3,4,5
1Child Health Evaluative Sciences, Peter Gilgan Centre for Research and Learning, The Hospital for Sick Children, Toronto, ON, Canada. yanara.marks@sickkids.ca.
PharmacoEconomics
|April 12, 2024
概括
在卫生技术评估 (HTA) 中使用R编程语言的障碍包括人力资源限制和缺乏机构接受. 促进者包括标准化,培训和加强利益相关者沟通,以促进HTA中的R采用.
科学领域:
- 医疗技术评估 (HTA) 是指对医疗技术进行评估.
- 卫生经济学 卫生经济学
- 药物经济学 药物经济学
- 决策建模 决策建模
背景情况:
- 商业软件主导卫生技术评估 (HTA) 决策建模提交,尽管已知的局限性.
- 开源编程语言R为HTA提供了效率,透明度和可重复性优势.
- 在HTA中R的有限采用需要探索障碍和促进者.
研究的目的:
- 调查R在卫生技术评估 (HTA) 中缓慢吸收的主要原因.
- 确定用于增加在HTA过程中R的使用的实际促进者.
主要方法:
- 涉及两个半结构化的焦点小组讨论的定性研究.
- 来自政府,咨询,制药和学术领域的24个主要利益相关者参加了会议.
- 讨论的重点是确定在HTA中采用R的障碍和促进者.
主要成果:
- 主要障碍包括人力资源的限制 (缺乏培训,优先级,协作,对变革的抵抗).
- 缺乏HTA机构的接受和对R提交的明确指导是重要的障碍.
- 关于已被接受的R包,模型结构和机构间标准的沟通不足,阻碍了采用.
结论:
- 标准化对于促进决策模型共享,编码一致性和HTA国家调整至关重要.
- 短期促进者包括开发培训材料和研讨会.
- 加强利益相关者的沟通和参与可以解决结构性障碍,并增加R在HTA中的使用激励.
相关概念视频
Introduction to R
265
R is a powerful software environment for statistical computing and graphics. Originating as an implementation of the S language, developed at Bell Laboratories, R has evolved into a robust, open-source statistical software favored by statisticians and data scientists worldwide. Its comprehensive suite includes data manipulation, calculation, and graphical display capabilities, making it versatile for data analysis and visualization. Its programming language is at the core of R's...
265
Methods of Documentation VI: Case Management Model
570
The case management model is a multidisciplinary approach that involves healthcare professionals from diverse disciplines, such as physicians, nurses, therapists, social workers, and pharmacists, working collaboratively to address the various needs of patients. Each healthcare professional brings unique expertise and perspectives, contributing to a more comprehensive understanding of the patient's condition and tailoring treatment plans accordingly.
For example, a patient with a chronic...
For example, a patient with a chronic...
570
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
126
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
126
Models of Health Promotion and Illness Prevention I
2.0K
A model is a theoretical way to understand a concept or an idea. Models can overcome barriers to health regardless of diverse economic and cultural backgrounds. In addition, models make the task easier by providing different ways to approach complex issues. There are two major health promotion models: the health belief model and the health promotion model.
The health belief model (HBM) attempts to predict health-related behavior in specific belief patterns. According to the HBM, a person's...
The health belief model (HBM) attempts to predict health-related behavior in specific belief patterns. According to the HBM, a person's...
2.0K
Pharmacokinetic Models: Comparison and Selection Criterion
70
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
70
Hazard Ratio
116
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
116


